Du är här

2015-08-13

Orion Oyj: 200,000 Orion Corporation A shares converted into B shares

ORION CORPORATION STOCK EXCHANGE RELEASE 13 AUGUST 2015 at 9.30 a.m. EEST

200,000 Orion Corporation A shares converted into B shares
In accordance with Section 3 of the Articles of Association of Orion
Corporation, 200,000 A shares have been converted into 200,000 B shares. The
conversion has been entered into the Trade Register on 13 August 2015.
The total number of shares in Orion Corporation is 141,257,828 which, after
the conversion, consists of 39,425,774 A shares and 101,832,054 B shares.

Orion Corporation

---------------------------------------------
| Olli Huotari Jari Karlson |
|SVP, Corporate Functions |
| CFO |
---------------------------------------------

Publisher:

Orion Corporation
Communications
Orionintie 1A, FI-02200 Espoo, Finland
Homepage:www.orion.fi

Orion is a globally operating Finnish company developing pharmaceuticals and
diagnostic tests - a builder of well-being. Orion develops, manufactures and
markets human and veterinary pharmaceuticals, active pharmaceutical
ingredients and diagnostic tests. The company is continuously developing new
drugs and treatment methods. The core therapy areas of Orion's pharmaceutical
R&D are central nervous system (CNS) disorders, oncology and respiratory for
which Orion developes inhaled Easyhaler® pulmonary drugs.
Orion's net sales in 2014 amounted to EUR 1,015 million and the company had
about 3,500 employees. Orion's A and B shares are listed on NASDAQ Helsinki.

---------------------------------------

This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Orion Oyj via Globenewswire

HUG#1945341

Författare Hugin

Tala om vad ni tycker

Tala om vad ni tycker

Ni är just nu inne på en betaversion av nya aktiespararna. Lämna gärna feedback på vad ni tycker i formuläret nedan.